561
Views
4
CrossRef citations to date
0
Altmetric
Meeting Report

Screening Europe 2010: an update about the latest technologies and applications in high-throughput screening

Pages 559-563 | Published online: 09 Jan 2014

References

  • Bleicher KH, Böhm HJ, Müller K, Alanine AI. Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov.2(5), 369–378 (2003).
  • Feng Y, Mitchison TJ, Bender A, Young DW, Tallarico JA. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat. Rev. Drug Discov.8(7), 567–578 (2009).
  • Eglen RM. Primary, iPS and stem cells: emerging tools for HTS? Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Eglen RM, Gilchrist A, Reisine T. An overview of drug screening using primary and embryonic stem cells. Comb. Chem. High Throughput Screen.11(7), 566–572 (2008).
  • Cawkill D. Cell based assay development – it all starts with the cell. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Desbordes SC. High-throughput screening in human embryonic stem cells for drug discovery. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Desbordes SC, Placantonakis DG, Ciro A et al. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell2(6), 602–12 (2008).
  • Ivanov I. sciWIFTER applications for in vitro cellular screening. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Augustin M. Technology spotlight: illuminating your pathway to discovery: cell based assays for efficacy and safety profiling. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Merten CA. Indirect inhibition assays and droplet-based microfluidics. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Granieri L, Miller OJ, Griffiths AD, Merten CA. A competition-based assay for the screening of species-specific antibiotics. J. Antimicrob. Chemother.64(1), 62–68 (2009).
  • Clausell-Tormos J, Griffiths AD, Merten CA. Coupling the inhibition of viral transduction with a positive fluorescence signal. Comb. Chem. High Throughput Screen.13(4), 352–357 (2010).
  • Callol-Massot C. Validation of a zebrafish automated screening platform. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Sundberg F. Using label-free technologies to improve screening and hit validation. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Bomke J. Rapid, label-free screening and affinity determination of fragments binding specifically to drug targets. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Albert J. Challenges and successes in fragment-based lead generation: increasing impact across drug discovery. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Teague SJ, Davis AM, Leeson PD, Oprea T. The design of leadlike combinatorial libraries. Angew. Chem. Int. Ed. Engl.38(24), 3743–3748 (1999).
  • Uitdehaag J. Screening for selectivity. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Graczyk PP. Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases. J. Med. Chem.50(23), 5773–5779 (2007).
  • Karaman MW, Herrgard S, Treiber DK et al. A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol.26(1), 127–132 (2008).
  • Walters RW, Shukla AK, Kovacs JJ et al. β-arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J. Clin. Invest.119(5), 1312–1321 (2009).
  • Taggart AK, Kero J, Gan X et al. (D)-β-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem.280(29), 26649–26652 (2005).
  • Milligan SE. What are the right assays to select? Studies with receptors for free fatty acids. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Clausell-Tormos J, Lieber D, Baret JC et al. Droplet-based microfluidic platforms for the encapsulation and screening of mammalian cells and multicellular organisms. Chem. Biol.15(5), 427–437 (2008).
  • Sklar L. Multiplex target screening by high throughput flow cytometry. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Granieri L, Baret J-C, Griffiths AD, Merten CA. High-throughput screening of enzymes by retroviral display using droplet-based microfluidics. Chem. Biol.17(3), 229–235 (2010).
  • Clausell-Tormos J, Griffiths AD, Merten CA. An automated two-phase microfluidic system for kinetic analyses and the screening of compound libraries. Lab. Chip DOI: 10.1039/b921754a (2010) (Epub ahead of print).
  • Ellson R. Total assay assembly enabled with acoustic droplet ejection. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Brode T. i-doT (immediate drop on demand technology) fast and direct sample handling for MWPs. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • McNaughton P. Thermo-TRP ion channels as drug targets. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Lea W. A high-throughput approach for identification of candidate general anesthetics. Presented at: 7th Annual Screening Europe Conference. Barcelona, Spain, 11–12 February 2010.
  • Vedula LS, Brannigan G, Economou NJ et al. A unitary anesthetic binding site at high resolution. J. Biol. Chem.284(36), 24176–24184 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.